BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23612448)

  • 1. Supramolecular filaments containing a fixed 41% paclitaxel loading.
    Lin R; Cheetham AG; Zhang P; Lin YA; Cui H
    Chem Commun (Camb); 2013 May; 49(43):4968-70. PubMed ID: 23612448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic dual-targeting hydrogel improves targeting and anticancer effect of Taxol in vitro and in vivo.
    Shu C; Li R; Yin Y; Yin D; Gu Y; Ding L; Zhong W
    Chem Commun (Camb); 2014 Dec; 50(97):15423-6. PubMed ID: 25349928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance.
    Jia L; Li Z; Shen J; Zheng D; Tian X; Guo H; Chang P
    Int J Pharm; 2015 Jul; 489(1-2):318-30. PubMed ID: 25956050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction responsive liposomes based on paclitaxel-ss-lysophospholipid with high drug loading for intracellular delivery.
    Wang Z; Ling L; Du Y; Yao C; Li X
    Int J Pharm; 2019 Jun; 564():244-255. PubMed ID: 31022499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior antitumor effect of extremely high drug loading self-assembled paclitaxel nanofibers.
    Xu H; Lu X; Li J; Ding D; Wang H; Li X; Xie W
    Int J Pharm; 2017 Jun; 526(1-2):217-224. PubMed ID: 28473236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells.
    Watanabe K; Nishio Y; Makiura R; Nakahira A; Kojima C
    Int J Pharm; 2013 Mar; 446(1-2):81-6. PubMed ID: 23402979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel and its formulations.
    Singla AK; Garg A; Aggarwal D
    Int J Pharm; 2002 Mar; 235(1-2):179-92. PubMed ID: 11879753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
    Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled Tat nanofibers as effective drug carrier and transporter.
    Zhang P; Cheetham AG; Lin YA; Cui H
    ACS Nano; 2013 Jul; 7(7):5965-77. PubMed ID: 23758167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
    Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
    Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
    Hu L; Li M; Zhang Z; Shen Y; Guo S
    Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery.
    Almeida A; Silva D; Gonçalves V; Sarmento B
    Drug Deliv Transl Res; 2018 Apr; 8(2):387-397. PubMed ID: 28116655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture.
    Ansari KA; Torne SJ; Vavia PR; Trotta F; Cavalli R
    Curr Drug Deliv; 2011 Mar; 8(2):194-202. PubMed ID: 21235471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
    Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H
    Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.